Skip to main content
Erschienen in: Journal of General Internal Medicine 5/2018

05.02.2018 | Perspective

Balancing the Rights to Protection and Participation: A Call for Expanded Access to Ethically Conducted Correctional Health Research

verfasst von: Cyrus Ahalt, MPP, Craig Haney, PhD, JD, Stuart Kinner, PhD, Brie Williams, MD, MS

Erschienen in: Journal of General Internal Medicine | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Incarcerated individuals, over 95% of whom are eventually released, experience high burdens of chronic disease and behavioral health and social risk factors. Understanding the health needs of this population is critical to ensuring that general medicine physicians in prisons and in the community are adequately prepared to meet those needs. However, people in prison are significantly underrepresented in health research. In response to historical exploitation of prisoners in medical experimentation, federal guidelines appropriately require additional oversight for, and limit the scope of, research in prisons. Yet, according to a 2006 Institute of Medicine report, these requirements have produced inconsistent local regulations that often limit opportunities for incarcerated individuals to participate in research, and can slow the development of innovative medical interventions to improve their health. In this article, we describe the historical context surrounding regulations on research involving individuals in prison, the harms that can arise from excessive limitations to research in such settings, and the benefits of greater access to ethically conducted research in prison. We conclude with recommended actions that can be taken by general medicine researchers, correctional leaders, and policymakers to achieve consistent access to health research for incarcerated populations.
Literatur
1.
Zurück zum Zitat Drucker E. A Plague of Prisons: The Epidemiology of Mass Incarceration in America. New York: New Press; 2011. Drucker E. A Plague of Prisons: The Epidemiology of Mass Incarceration in America. New York: New Press; 2011.
3.
Zurück zum Zitat Dumont DM, Allen SA, Brockmann BW, Alexander NE, Rich JD. Incarceration, community health, and racial disparities. J Health Care Poor Underserved. 2013;24(1):78–88.CrossRefPubMed Dumont DM, Allen SA, Brockmann BW, Alexander NE, Rich JD. Incarceration, community health, and racial disparities. J Health Care Poor Underserved. 2013;24(1):78–88.CrossRefPubMed
4.
Zurück zum Zitat Peters RH, Wexler HK, Lurigio AJ. Co-Occurring Substance Use and Mental Disorders in the Criminal Justice System: A New Frontier of Clinical Practice and Research. Psychiatric Rehab J. 2015;38(1):1–6.CrossRef Peters RH, Wexler HK, Lurigio AJ. Co-Occurring Substance Use and Mental Disorders in the Criminal Justice System: A New Frontier of Clinical Practice and Research. Psychiatric Rehab J. 2015;38(1):1–6.CrossRef
5.
Zurück zum Zitat Binswanger IA, Krueger PM, Steiner JF. Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population. J Epidemiol Community Health. 2009;63(11):912–9.CrossRefPubMed Binswanger IA, Krueger PM, Steiner JF. Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population. J Epidemiol Community Health. 2009;63(11):912–9.CrossRefPubMed
6.
Zurück zum Zitat Mallik-Kane K, Visher C. Health and Prisoner Reentry: How Physical, Mental, and Substance Abuse Conditions Shape the Process of Reintegration. Washington, DC: Urban Institute;2008. Mallik-Kane K, Visher C. Health and Prisoner Reentry: How Physical, Mental, and Substance Abuse Conditions Shape the Process of Reintegration. Washington, DC: Urban Institute;2008.
7.
Zurück zum Zitat Western B, Braga AA, Davis J, Sirois C. Stress and Hardship after Prison. Am J Sociol. 2015;120(5):1512–47.CrossRefPubMed Western B, Braga AA, Davis J, Sirois C. Stress and Hardship after Prison. Am J Sociol. 2015;120(5):1512–47.CrossRefPubMed
8.
Zurück zum Zitat Wildeman C, Muller C. Mass imprisonment and inequality in health and family life. Ann Rev Law Soc Sci. 2012;8:11–30.CrossRef Wildeman C, Muller C. Mass imprisonment and inequality in health and family life. Ann Rev Law Soc Sci. 2012;8:11–30.CrossRef
9.
Zurück zum Zitat Comfort M. Doing Time Together: Love and Family in the Shadow of the Prison. Chicago, IL: University of Chicago Press; 2008.CrossRef Comfort M. Doing Time Together: Love and Family in the Shadow of the Prison. Chicago, IL: University of Chicago Press; 2008.CrossRef
10.
Zurück zum Zitat Greifinger R, ed. Public Health Behind Bars: from Prisons to Communities. New York: Springer; 2007. Greifinger R, ed. Public Health Behind Bars: from Prisons to Communities. New York: Springer; 2007.
11.
Zurück zum Zitat Cloud D. On Life Support: Public Health in the Age of Mass Incarceration. New York: Vera Institute of Justice; 2014. Cloud D. On Life Support: Public Health in the Age of Mass Incarceration. New York: Vera Institute of Justice; 2014.
12.
Zurück zum Zitat Ahalt C, Binswanger IA, Steinman M, Tulsky J, Williams BA. Confined to ignorance: the absence of prisoner information from nationally representative health data sets. J Gen Intern Med. 2012;27(2):160–6.CrossRefPubMed Ahalt C, Binswanger IA, Steinman M, Tulsky J, Williams BA. Confined to ignorance: the absence of prisoner information from nationally representative health data sets. J Gen Intern Med. 2012;27(2):160–6.CrossRefPubMed
13.
14.
15.
Zurück zum Zitat Fox AD, Anderson MR, Bartlett G, Valverde J, Starrels JL, Cunningham CO. Health outcomes and retention in care following release from prison for patients of an urban post-incarceration transitions clinic. J Health Care Poor Underserved. 2014;25(3):1139–52.CrossRefPubMedPubMedCentral Fox AD, Anderson MR, Bartlett G, Valverde J, Starrels JL, Cunningham CO. Health outcomes and retention in care following release from prison for patients of an urban post-incarceration transitions clinic. J Health Care Poor Underserved. 2014;25(3):1139–52.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Baillargeon J, Penn JV, Knight K, Harzke AJ, Baillargeon G, Becker EA. Risk of reincarceration among prisoners with co-occurring severe mental illness and substance use disorders. Admin Pol Ment Health. 2010;37(4):367–74.CrossRef Baillargeon J, Penn JV, Knight K, Harzke AJ, Baillargeon G, Becker EA. Risk of reincarceration among prisoners with co-occurring severe mental illness and substance use disorders. Admin Pol Ment Health. 2010;37(4):367–74.CrossRef
17.
Zurück zum Zitat Committee on Causes and Consequences of High Rates of Incarceration; Committee on Law and Justice; Division of Behavioral and Social Sciences and Education; National Research Council; Board on the Health of Select Populations; Institute of Medicine. Health and Incarceration: A Workshop Summary. A. Smith, Rapporteur. Washington, DC: National Academies Press; 2013. Committee on Causes and Consequences of High Rates of Incarceration; Committee on Law and Justice; Division of Behavioral and Social Sciences and Education; National Research Council; Board on the Health of Select Populations; Institute of Medicine. Health and Incarceration: A Workshop Summary. A. Smith, Rapporteur. Washington, DC: National Academies Press; 2013.
18.
Zurück zum Zitat Ahalt C, Bolano M, Wang EA, Williams B. The state of research funding from the National Institutes of Health for criminal justice health research. Ann Intern Med. 2015;162(5):345–52.CrossRefPubMedPubMedCentral Ahalt C, Bolano M, Wang EA, Williams B. The state of research funding from the National Institutes of Health for criminal justice health research. Ann Intern Med. 2015;162(5):345–52.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Gostin LO. Biomedical research involving prisoners: ethical values and legal regulation. JAMA 2007;297(7):737–40.CrossRefPubMed Gostin LO. Biomedical research involving prisoners: ethical values and legal regulation. JAMA 2007;297(7):737–40.CrossRefPubMed
20.
Zurück zum Zitat Institute of Medicine Committee on Ethical Considerations for Revisions to DHHS Regulations for Protection of Prisoners Involved in Research. Gostin LO, Vanchieri C, Pope A, eds. Ethical considerations for research involving prisoners. Washington, DC: National Academies Press; 2006. Available at: https://www.ncbi.nlm.nih.gov/books/NBK19882/. Last accessed 16 May 2017. Institute of Medicine Committee on Ethical Considerations for Revisions to DHHS Regulations for Protection of Prisoners Involved in Research. Gostin LO, Vanchieri C, Pope A, eds. Ethical considerations for research involving prisoners. Washington, DC: National Academies Press; 2006. Available at: https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK19882/​. Last accessed 16 May 2017.
21.
23.
Zurück zum Zitat Harkness JM. Nuremberg and the issue of wartime experiments on US prisoners. The Green Committee. JAMA. 1996;276(20):1672–5.CrossRefPubMed Harkness JM. Nuremberg and the issue of wartime experiments on US prisoners. The Green Committee. JAMA. 1996;276(20):1672–5.CrossRefPubMed
24.
Zurück zum Zitat McDermott BE. Coercion in research: are prisoners the only vulnerable population? J Am Acad Psychiatry Law. 2013;41(1):8–13.PubMed McDermott BE. Coercion in research: are prisoners the only vulnerable population? J Am Acad Psychiatry Law. 2013;41(1):8–13.PubMed
25.
Zurück zum Zitat Paul C, Brookes B. The Rationalization of Unethical Research: Revisionist Accounts of the Tuskegee Syphilis Study and the New Zealand "Unfortunate Experiment". Am J Public Health. 2015;105(10):e12–9. Paul C, Brookes B. The Rationalization of Unethical Research: Revisionist Accounts of the Tuskegee Syphilis Study and the New Zealand "Unfortunate Experiment". Am J Public Health. 2015;105(10):e12–9.
29.
Zurück zum Zitat Porter JP. The federal policy for the protection of human subjects. IRB Rev Hum Subj Res. 1991;13(5):8–9. Porter JP. The federal policy for the protection of human subjects. IRB Rev Hum Subj Res. 1991;13(5):8–9.
30.
Zurück zum Zitat Kimmelman J. Valuing risk: the ethical review of clinical trial safety. Kennedy Inst Ethics J. 2004;14(4):369–93.CrossRefPubMed Kimmelman J. Valuing risk: the ethical review of clinical trial safety. Kennedy Inst Ethics J. 2004;14(4):369–93.CrossRefPubMed
31.
Zurück zum Zitat Siegel JE, Roberts MJ. Reforming FDA Policy Lessons from the AIDS Experience. Regulation (Cato Review of Business & Government). 1991;14:71–7. Siegel JE, Roberts MJ. Reforming FDA Policy Lessons from the AIDS Experience. Regulation (Cato Review of Business & Government). 1991;14:71–7.
33.
Zurück zum Zitat Novick A. Civil disobedience in time of AIDS. Hast Cent Rep. 1989;19(6):35–6.CrossRef Novick A. Civil disobedience in time of AIDS. Hast Cent Rep. 1989;19(6):35–6.CrossRef
34.
Zurück zum Zitat Liu KA, Mager NA. Women’s involvement in clinical trials: historical perspective and future implications. Pharm Pract (Granada). 2016;14(1):708.CrossRef Liu KA, Mager NA. Women’s involvement in clinical trials: historical perspective and future implications. Pharm Pract (Granada). 2016;14(1):708.CrossRef
35.
Zurück zum Zitat Thomas SB, Quinn SC, Butler J, Fryer CS, Garza MA. Toward a fourth generation of disparities research to achieve health equity. Annu Rev Public Health. 2011;32:399–416.CrossRefPubMedPubMedCentral Thomas SB, Quinn SC, Butler J, Fryer CS, Garza MA. Toward a fourth generation of disparities research to achieve health equity. Annu Rev Public Health. 2011;32:399–416.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Nunn A, Cornwall A, Fu J, Bazerman L, Loewenthal H, Beckwith C. Linking HIV-positive jail inmates to treatment, care, and social services after release: results from a qualitative assessment of the COMPASS Program. J Urban Health. 2010;87(6):954–68.CrossRefPubMedPubMedCentral Nunn A, Cornwall A, Fu J, Bazerman L, Loewenthal H, Beckwith C. Linking HIV-positive jail inmates to treatment, care, and social services after release: results from a qualitative assessment of the COMPASS Program. J Urban Health. 2010;87(6):954–68.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Zaller ND, Holmes L, Dyl AC, et al. Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved. 2008;19(2):522–31.CrossRefPubMed Zaller ND, Holmes L, Dyl AC, et al. Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved. 2008;19(2):522–31.CrossRefPubMed
39.
Zurück zum Zitat McKenzie M, Nunn A, Zaller ND, Bazazi AR, Rich JD. Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice. J Opioid Manag. 2009;5(4):219–27.CrossRefPubMedPubMedCentral McKenzie M, Nunn A, Zaller ND, Bazazi AR, Rich JD. Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice. J Opioid Manag. 2009;5(4):219–27.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Rich JD, McKenzie M, Larney S, et al. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet. 2015;386(9991):350–9.CrossRefPubMedPubMedCentral Rich JD, McKenzie M, Larney S, et al. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet. 2015;386(9991):350–9.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Zaller N, McKenzie M, Friedmann PD, Green TC, McGowan S, Rich JD. Initiation of buprenorphine during incarceration and retention in treatment upon release. J Subst Abus Treat. 2013;45(2):222–6.CrossRef Zaller N, McKenzie M, Friedmann PD, Green TC, McGowan S, Rich JD. Initiation of buprenorphine during incarceration and retention in treatment upon release. J Subst Abus Treat. 2013;45(2):222–6.CrossRef
46.
Zurück zum Zitat Thomas EG, Spittal MJ, Taxman FS, Kinner SA. Health-related factors predict return to custody in a large cohort of ex-prisoners: new approaches to predicting re-incarceration. Health Justice. 2015;3(10). Thomas EG, Spittal MJ, Taxman FS, Kinner SA. Health-related factors predict return to custody in a large cohort of ex-prisoners: new approaches to predicting re-incarceration. Health Justice. 2015;3(10).
47.
Zurück zum Zitat Schittker J, Massoglia M, Uggen C. Incarceration and the health of the African American community. Du Bois Rev. 2011;8(1):133–41.CrossRef Schittker J, Massoglia M, Uggen C. Incarceration and the health of the African American community. Du Bois Rev. 2011;8(1):133–41.CrossRef
Metadaten
Titel
Balancing the Rights to Protection and Participation: A Call for Expanded Access to Ethically Conducted Correctional Health Research
verfasst von
Cyrus Ahalt, MPP
Craig Haney, PhD, JD
Stuart Kinner, PhD
Brie Williams, MD, MS
Publikationsdatum
05.02.2018
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 5/2018
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4318-9

Weitere Artikel der Ausgabe 5/2018

Journal of General Internal Medicine 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.